Skip to content

Clinical trials

Leukemia, Lymphocytic, Chronic, B-Cell trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Country / region: India Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20091
20181
20191
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Johnson & Johnson Private Limited2
Novartis Pharmaceuticals2
All India Institute of Medical Sciences1
Aurigene Discovery Technologies Limited1
Biogen1
National Institutes of Health Clinical Center (CC)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell10
Lymphoma, Mantle-Cell4
Recurrence4
Leukemia, B-Cell2
Lymphoma, Non-Hodgkin2
Neoplasms2
Burkitt Lymphoma1
Dendritic Cell Sarcoma, Interdigitating1
Hodgkin Disease1
Leukemia1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.